Venture investing at highest since '01
Biotech leads surge; firms in region net $975.5m in quarter
Fueled by a surge in biotechnology funding, first-quarter venture capital investing climbed to its highest level nationally since the last three months of 2001, according to the quarterly MoneyTree report set to be released today. (Full article: 653 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
